Total Payments
$1,715
2024 Payments
$851.40
Companies
20
Transactions
84
Medicare Patients
1,911
Medicare Billing
$264,120
Payment Breakdown by Category
Food & Beverage$1,661 (96.8%)
Education$54.78 (3.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,661 | 80 | 96.8% |
| Education | $54.78 | 4 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $287.08 | 15 | $0 (2024) |
| Gilead Sciences, Inc. | $286.94 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $175.27 | 8 | $0 (2024) |
| Lilly USA, LLC | $135.20 | 7 | $0 (2024) |
| Daiichi Sankyo Inc. | $124.84 | 6 | $0 (2024) |
| Celgene Corporation | $105.47 | 6 | $0 (2024) |
| Seagen Inc. | $95.84 | 5 | $0 (2023) |
| ABBVIE INC. | $84.68 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $59.10 | 3 | $0 (2024) |
| Incyte Corporation | $55.19 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $851.40 | 42 | Gilead Sciences, Inc. ($187.87) |
| 2023 | $653.90 | 32 | Gilead Sciences, Inc. ($87.15) |
| 2022 | $76.37 | 5 | Celgene Corporation ($31.07) |
| 2021 | $30.93 | 2 | AstraZeneca Pharmaceuticals LP ($19.01) |
| 2019 | $11.05 | 1 | PFIZER INC. ($11.05) |
| 2018 | $91.65 | 2 | PFIZER INC. ($67.87) |
All Payment Transactions
84 individual payment records from CMS Open Payments — Page 3 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/18/2023 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/09/2023 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: ONCOLOGY | ||||||
| 08/02/2023 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $18.89 | General |
| Category: Hematology | ||||||
| 07/28/2023 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $28.76 | General |
| Category: Oncology | ||||||
| 07/26/2023 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: Oncology | ||||||
| 06/28/2023 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Oncology | ||||||
| 06/21/2023 | Incyte Corporation | PEMAZYRE (Drug), MONJUVI | Food and Beverage | Cash or cash equivalent | $14.89 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 06/19/2023 | Foundation Medicine, Inc. | FOUNDATIONONE LIQUID CDX | Food and Beverage | In-kind items and services | $15.61 | General |
| 06/15/2023 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Oncology | ||||||
| 06/14/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: ONCOLOGY | ||||||
| 05/25/2023 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $31.71 | General |
| Category: ONC | ||||||
| 05/23/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Oncology | ||||||
| 05/17/2023 | PFIZER INC. | INLYTA (Drug), BAVENCIO, XTANDI | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: ONCOLOGY | ||||||
| 05/10/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: ONCOLOGY | ||||||
| 04/27/2023 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: ONCOLOGY | ||||||
| 04/25/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: Oncology | ||||||
| 04/20/2023 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: ONC | ||||||
| 04/13/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: ONCOLOGY | ||||||
| 04/05/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $21.26 | General |
| Category: Oncology | ||||||
| 03/31/2023 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $18.34 | General |
| 03/15/2023 | Celgene Corporation | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $16.38 | General |
| Category: Oncology | ||||||
| 03/08/2023 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Oncology | ||||||
| 02/08/2023 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Oncology | ||||||
| 01/04/2023 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Oncology | ||||||
| 12/14/2022 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $15.43 | General |
| Category: Hematology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 444 | 837 | $142,733 | $57,675 |
| 2022 | 4 | 477 | 964 | $161,429 | $65,217 |
| 2021 | 3 | 478 | 1,093 | $184,012 | $76,590 |
| 2020 | 5 | 512 | 1,133 | $187,401 | $64,637 |
Total Patients
1,911
Total Services
4,027
Medicare Billing
$264,120
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 357 | 735 | $116,264 | $46,457 | 40.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 54 | 69 | $15,474 | $6,753 | 43.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 21 | 21 | $6,999 | $2,830 | 40.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 12 | 12 | $3,996 | $1,636 | 40.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 393 | 867 | $136,895 | $55,663 | 40.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 44 | 57 | $12,489 | $5,674 | 45.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 23 | 23 | $7,659 | $2,491 | 32.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $4,386 | $1,388 | 31.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 396 | 999 | $158,282 | $65,520 | 41.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 37 | 49 | $10,745 | $5,094 | 47.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 33 | 33 | $10,989 | $4,266 | 38.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 12 | 12 | $3,996 | $1,710 | 42.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 406 | 996 | $155,376 | $52,970 | 34.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 34 | 34 | $11,322 | $4,166 | 36.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 35 | 52 | $11,312 | $4,006 | 35.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 23 | 37 | $5,513 | $2,015 | 36.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 14 | 14 | $3,878 | $1,480 | 38.2% |
About Dr. Kim Gococo, MD
Dr. Kim Gococo, MD is a Hematology & Oncology healthcare provider based in Greenville, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1407851793.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kim Gococo, MD has received a total of $1,715 in payments from pharmaceutical and medical device companies, with $851.40 received in 2024. These payments were reported across 84 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,661).
As a Medicare-enrolled provider, Gococo has provided services to 1,911 Medicare beneficiaries, totaling 4,027 services with total Medicare billing of $264,120. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Greenville, SC
- Active Since 06/15/2005
- Last Updated 12/20/2022
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1407851793
Products in Payments
- IBRANCE (Drug) $213.30
- VERZENIO (Drug) $135.20
- Enhertu (Drug) $88.66
- Fabhalta (Drug) $87.22
- INLYTA (Drug) $62.73
- Trodelvy (Drug) $56.80
- Nubeqa (Drug) $53.44
- VENCLEXTA (Drug) $50.38
- Pomalyst (Drug) $49.96
- OPDUALAG (Drug) $45.78
- PADCEV (Biological) $44.66
- KEYTRUDA (Biological) $43.81
- Padcev (Drug) $40.65
- PEMAZYRE (Drug) $38.29
- KISQALI (Drug) $35.51
- TUKYSA (Drug) $35.18
- ELAHERE (Drug) $34.30
- PROMACTA (Drug) $28.76
- JADENU (Drug) $23.78
- Lenvima (Drug) $21.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Greenville
Dr. Suzanne Fanning, D.o, D.O
Hematology & Oncology — Payments: $1.3M
Hematology & Oncology $1.3M
Dr. Joe Stephenson, Md, MD
Hematology & Oncology — Payments: $137,970
Hematology & Oncology $137,970
Dr. Paul Walker, M.d, M.D
Hematology & Oncology — Payments: $66,454
Hematology & Oncology $66,454
Dr. Darla Liles, Md, MD
Hematology & Oncology — Payments: $49,052
Hematology & Oncology $49,052
William Edenfield, Md, MD
Hematology & Oncology — Payments: $31,038
Hematology & Oncology $31,038
Dr. Raid Aljumaily, M.d, M.D
Hematology & Oncology — Payments: $21,498
Hematology & Oncology $21,498